RETRACTED: Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer
Main Authors: | Hao Ding, Wei Wen, Qingqing Ding, Xin Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-10-01
|
Series: | Cancer Control |
Online Access: | https://doi.org/10.1177/1073274820964783 |
Similar Items
-
Retraction: Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer
Published: (2023-07-01) -
Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
by: WangYu Zhu, et al.
Published: (2016-01-01) -
miR-21, miR-93, miR-191, miR-let-7b, and miR-499 Expression Level in Plasma and Cerebrospinal Fluid in Patients with Prolonged Disorders of Consciousness
by: Tatiana A. Petrova, et al.
Published: (2022-12-01) -
miR-191: An emerging player in disease biology
by: Ritu eKulshreshtha, et al.
Published: (2014-04-01) -
Diagnostic performance of miR-21, miR-124, miR-132,
and miR-200b serums in post-stroke cognitive impairment patients
by: Mei Yuan, et al.
Published: (2022-06-01)